Page last updated: 2024-08-23

daunorubicin and valinomycin

daunorubicin has been researched along with valinomycin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's5 (71.43)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hansch, C; Khwaja, TA; Selassie, CD1
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ1
Bolard, J; Henry, N1
Bolhuis, H; Driessen, AJ; Konings, WN; Molenaar, D; Poelarends, G; Poolman, B; van Veen, HW1
Futai, M; Manabe, T; Moriyama, Y; Tashiro, Y; Yoshimori, T1
Damjanovich, S; Gaspar, R; Goda, K; Krasznai, Z; Lankelma, J; Szabó, G; Westerhoff, HV1
de Vries, EG; Garnier-Suillerot, A; Moretti, JL; Vergote, J1

Other Studies

7 other study(ies) available for daunorubicin and valinomycin

ArticleYear
Structure-activity relationships of antineoplastic agents in multidrug resistance.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:7

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured

1990
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
    Pharmaceutical research, 2003, Volume: 20, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport, Active; Biomarkers; Cells, Cultured; Drug Interactions; Fluorescent Dyes; Humans

2003
Synergistic incorporation of daunorubicin in erythrocytes in the presence of polyene antibiotics. Role of the membrane potential.
    Biochimica et biophysica acta, 1986, Jan-16, Volume: 854, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Azides; Buffers; Candicidin; Cations; Cell Membrane Permeability; Daunorubicin; Drug Synergism; Erythrocyte Membrane; Humans; Membrane Potentials; Potassium; Sodium Azide; Valinomycin

1986
Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis.
    Journal of bacteriology, 1994, Volume: 176, Issue:22

    Topics: Adenosine Triphosphate; Biological Transport; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethidium; Lactococcus lactis; Membrane Potentials; Mutation; Nigericin; Protons; Valinomycin; Vancomycin

1994
ATP-dependent uptake of anti-neoplastic agents by acidic organelles.
    Journal of biochemistry, 1994, Volume: 115, Issue:2

    Topics: Adenosine Triphosphate; Ammonium Chloride; Animals; Antineoplastic Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cattle; Cells, Cultured; Chromaffin Granules; Daunorubicin; Drug Resistance; Hydrogen-Ion Concentration; Mice; Nigericin; Organelles; Proteolipids; Proton-Translocating ATPases; Quinidine; Reserpine; Valinomycin; Vanadates; Verapamil

1994
Reversal of multidrug resistance by valinomycin is overcome by CCCP.
    Biochemical and biophysical research communications, 1996, Feb-15, Volume: 219, Issue:2

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Coloring Agents; Daunorubicin; Drug Resistance, Multiple; Humans; Ionophores; KB Cells; Kinetics; Potassium; Rhodamine 123; Rhodamines; Valinomycin; Vinblastine

1996
Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    European journal of biochemistry, 1998, Feb-15, Volume: 252, Issue:1

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Daunorubicin; Drug Resistance, Multiple; Humans; Kinetics; Membrane Potentials; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organotechnetium Compounds; Phenotype; Radiopharmaceuticals; Tumor Cells, Cultured; Valinomycin

1998